Skip to content

Clinical trials

Phase 2 Memory Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Memory Disorders Phase: Phase 2 Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20051
20061
20071
20083
20091
20102
20112
20125
20131
20142
20161
20172
20181
20201
20215
20231
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting5
Terminated3
Not yet recruiting2
Unknown status2
Withdrawn2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Avraham Pharmaceuticals Ltd2
Johns Hopkins University2
University of California, Los Angeles2
AbbVie1
Acumen Pharmaceuticals1
Alzheimer's Disease Cooperative Study (ADCS)1
Celgene Corporation1
Columbia University1
Eli Lilly and Company1
Emory University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Memory Disorders39
Alzheimer Disease20
Cognitive Dysfunction19
Dementia14
Nervous System Diseases3
Neurodegenerative Diseases3
Brain Diseases2
Fatigue2
Inflammation2
Mental Disorders2

Trials

Showing 51 to 39 of 39. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.